Aidapak Recalls Pioglitazone Tablets Due to Potential Labeling Errors
Aidapak Services, LLC is recalling Pioglitazone HCL 15 mg tablets because they may have been mislabeled as Doxycycline or Lovastatin.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (mislabeling) without reported illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
Aidapak Services, LLC is recalling Pioglitazone HCL, Tablet, 15 mg (NDC 00093204856) due to a labeling error. The recall was initiated because the product may have been mislabeled as Doxycycline Monohydrate, Capsule, 100 mg, or Lovastatin, Tablet, 20 mg.
The affected Pioglitazone HCL tablets were repacked and distributed in Arizona, California, Oregon, and Washington. The recall covers specific lots with pedigree AD52778_70 (expiration 5/21/2014) and pedigree W003264 (expiration 6/17/2014).
Consumers and healthcare providers should check their inventory for these specific lot numbers and stop using the product if it matches the description. They should contact their pharmacist or the recalling firm for instructions on returning the product.
The recalled product
- Product
- PIOGLITAZONE HCL, Tablet, 15 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093204856.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 90
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- PIOGLITAZONE HCL
- Tablet
- 15 mg has the following codes: Pedigree: AD52778_70
- EXP: 5/21/2014
- Pedigree: W003264
- EXP: 6/17/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- SevereAidapak Recalls Propranolol HCL Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Pyridoxine HCL Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Doxycycline Hyclate Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Tizanidine Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- SeverePimozide Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Doxycycline Capsules Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22